Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetesRASKIN, Philip.Diabetes/metabolism research and reviews (Print). 2008, Vol 24, Num 1, pp 3-13, issn 1520-7552, 11 p.Article

Diabetes is a cardiovascular disease: new considerations for pharmacological managementRASKIN, Philip.Journal of diabetes and its complications. 2003, Vol 17, Num 2, issn 1056-8727, 36 p., SUPConference Proceedings

Efficacy and safety of insulin detemirRASKIN, Philip.Endocrinology and metabolism clinics of North America. 2007, Vol 36, pp 21-32, issn 0889-8529, 12 p., SUP1Article

Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: Clinical and biochemical differencesNEWTON, Christopher A; RASKIN, Philip.Archives of internal medicine (1960). 2004, Vol 164, Num 17, pp 1925-1931, issn 0003-9926, 7 p.Article

Insulin analogs as a cornerstone of diabetes therapy: focus on insulin detemirRASKIN, Philip; LEROITH, Derek.Endocrinology and metabolism clinics of North America. 2007, Vol 36, issn 0889-8529, 52 p., SUP1Serial Issue

The effect of rosiglitazone on overweight subjects with type 1 diabetesSTROWIG, Suzanne M; RASKIN, Philip.Diabetes care. 2005, Vol 28, Num 7, pp 1562-1567, issn 0149-5992, 6 p.Article

Diabetic hypertriglyceridemia-induced acute pancreatitis masquerading as biliary pancreatitisHUANG, David B; RASKIN, Philip.Journal of diabetes and its complications. 2002, Vol 16, Num 2, pp 180-182, issn 1056-8727Article

Idiopathic Type 1 diabetesPINERO-PILONA, Antonio; RASKIN, Philip.Journal of diabetes and its complications. 2001, Vol 15, Num 6, pp 328-335, issn 1056-8727Article

Cardiovascular risk in diabetes A brief reviewMARKS, Jennifer B; RASKIN, Philip.Journal of diabetes and its complications. 2000, Vol 14, Num 2, pp 108-115, issn 1056-8727Article

Insulin detemir and basal insulin therapyRUSSELL-JONES, David L.Endocrinology and metabolism clinics of North America. 2007, Vol 36, pp 7-13, issn 0889-8529, 7 p., SUP1Article

Intractable vomiting in diabetic patientsAVILES-SANTA, Larissa; WOLFF, Timothy K; RASKIN, Philip et al.Journal of diabetes and its complications. 2003, Vol 17, Num 3, pp 145-152, issn 1056-8727, 8 p.Article

Intensive diabetes therapy and body weight : Focus on insulin detemirBUSH, Michael A.Endocrinology and metabolism clinics of North America. 2007, Vol 36, pp 33-44, issn 0889-8529, 12 p., SUP1Article

The diabetic lung : Relevance of alveolar microangiopathy for the use of inhaled insulinHSIA, Connie C. W; RASKIN, Philip.The American journal of medicine. 2005, Vol 118, Num 3, pp 205-211, issn 0002-9343, 7 p.Article

The treatment of hypertension in adult patients with diabetesARAUZ-PACHECO, Carlos; PARROTT, Marian A; RASKIN, Philip et al.Diabetes care. 2002, Vol 25, Num 1, pp 134-147, issn 0149-5992Article

Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type ₂ diabetesRASKIN, Philip; GYLVIN, Titus; WENG, Wayne et al.Diabetes/metabolism research and reviews (Print). 2009, Vol 25, Num 6, pp 542-548, issn 1520-7552, 7 p.Article

Pharmacology of insulin detemirKURTZHALS, Peter.Endocrinology and metabolism clinics of North America. 2007, Vol 36, pp 14-20, issn 0889-8529, 7 p., SUP1Article

Levemir® early clinical experience case seriesMAYERSON, Adam B.Endocrinology and metabolism clinics of North America. 2007, Vol 36, pp 45-52, issn 0889-8529, 8 p., SUP1Article

Reversible acute renal failure and nephrotic syndrome in a Type 1 diabetic patientAVILES-SANTA, Larissa; ALPERN, Robert; RASKIN, Philip et al.Journal of diabetes and its complications. 2002, Vol 16, Num 3, pp 249-254, issn 1056-8727Article

Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetesSTROWIG, Suzanne M; LARISSA AVILES-SANTA, M; RASKIN, Philip et al.Diabetes care. 2002, Vol 25, Num 10, pp 1691-1698, issn 0149-5992Article

Improved glycemic control without weight gain using Triple therapy in type 2 diabetesSTROWIG, Suzanne M; LARISSA AVILES-SANTA, M; RASKIN, Philip et al.Diabetes care. 2004, Vol 27, Num 7, pp 1577-1583, issn 0149-5992, 7 p.Article

Idiopathic type 1 diabetes in Dallas, Texas: A 5-year experiencePINERO-PILONA, Antonio; LITONJUA, Patrick; AVILES-SANTA, Larissa et al.Diabetes care. 2001, Vol 24, Num 6, pp 1014-1018, issn 0149-5992Article

β-Cell Function Preservation After 3.5 Years of Intensive Diabetes TherapyHARRISON, Lindsay B; ADAMS-HUET, Beverley; RASKIN, Philip et al.Diabetes care. 2012, Vol 35, Num 7, pp 1406-1412, issn 0149-5992, 7 p.Article

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trialORBAN, Tihamer; BUNDY, Brian; MORAN, Antoinette et al.Lancet (British edition). 2011, Vol 378, Num 9789, pp 412-419, issn 0140-6736, 8 p.Article

Hyperglycemia and Acute Coronary Syndrome : A Scientific Statement From the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and MetabolismDEEDWANIA, Prakash; KOSIBOROD, Mikhail; BARRETT, Eugene et al.Circulation (New York, N.Y.). 2008, Vol 117, Num 12, pp 1610-1619, issn 0009-7322, 10 p.Article

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of TreatmentORBAN, Tihamer; BUNDY, Brian; MORAN, Antoinette et al.Diabetes care. 2014, Vol 37, Num 4, pp 1069-1075, issn 0149-5992, 7 p.Article